Cancer Genetics Clinical Trial
Official title:
Adaptation to Living With a BRCA l/2 Mutation in Carriers and Their Partners
Verified date | November 22, 2016 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Background:
- Women who have a BRCA1/2 gene mutation have a very high risk of developing breast or
ovarian cancer. They are also at increased risk of other developing other cancers. Male
carriers are at increased risk for breast, prostate and other cancers. Testing for this
mutation and living with this increased risk can be a source of stress for both people with
the mutation and their partners. Researchers want to look at how well people adapt to living
with this type of cancer risk over time.
Objectives:
- To see how women with the BRCA1/2 gene mutation and their partners adapt to the stress of
long-term cancer risk.
Eligibility:
- Women at least 18 years of age who have a BRCA1/2 mutation, and their male or female
partners.
Design:
- This study involves a one-time self-administered questionnaire. Participants will be
recruited from local and national hereditary cancer support groups and cancer centers.
- There are two versions of the survey. One is for the woman with the BRCA1/2 gene
mutation. The other is for her partner.
- The survey will ask about risk perception, cancer worry, risk-related stress, and coping
and adaptation methods.
- Treatment will not be provided as part of this study.
Status | Completed |
Enrollment | 142 |
Est. completion date | February 20, 2014 |
Est. primary completion date | February 20, 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
- INCLUSION AND EXCLUSION CRITERIA: Participants will be women aged 18 or older who have a BRCA1/2 mutation and their (male or female) partners. Carriers must have no personal history of cancer, but partners will not be excluded based on cancer history. Participants will be asked to disclose their mutation status (BRCA1 or BRCA2), but no screening evaluation will be required. If only one member of a couple completes the survey, their data will be included in the individual level analysis, but excluded from the dyadic level analysis. |
Country | Name | City | State |
---|---|---|---|
United States | Johns Hopkins Bloomberg School of Public Health | Baltimore | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Human Genome Research Institute (NHGRI) | Johns Hopkins Bloomberg School of Public Health |
United States,
Berg CA, Upchurch R. A developmental-contextual model of couples coping with chronic illness across the adult life span. Psychol Bull. 2007 Nov;133(6):920-54. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the primary outcome is psychological adaptation | 1 time survey |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01562431 -
The Signal-Trial: Evaluation of a Screening Tool for Psychosocial Problems in Cancer Genetics
|
N/A | |
Completed |
NCT00339508 -
Exploratory Data Analysis for Disease Pedigrees and Cancer Genetics
|
||
Terminated |
NCT01374685 -
Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans
|